Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial

The Lancet

Volumn 379, Issue 9835, 2012, Pages 2449-2458

  Jamieson, Denise J ^a   Chasela, Charles S ^b   Hudgens, Michael G ^c   King, Caroline C ^a   Kourtis, Athena P ^a   Kayira, Dumbani ^b   Hosseinipour, Mina C ^b,c   Kamwendo, Deborah D ^b   Ellington, Sascha R ^a   Wiener, Jeffrey B ^a   Fiscus, Susan A ^c   Tegha, Gerald ^b   Mofolo, Innocent A ^b   Sichali, Dorothy S ^b   Adair, Linda S ^c   Knight, Rodney J ^d   Martinson, Francis ^b,c   Kacheche, Zebrone ^b   Soko, Alice ^b   Hoffman, Irving ^c   Van Der Horst, Charles ^c   more..

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF NORTH CAROLINA PROJECT   (Malawi)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d Principia International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; ZIDOVUDINE;

ADULT; ANTIVIRAL THERAPY; ARTICLE; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIARRHEA; DRUG DOSE INCREASE; DRUG ERUPTION; DRUG FATALITY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GROWTH DISORDER; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; INFANT NUTRITION; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALARIA; MALAWI; MATERNAL DISEASE; MENINGITIS; MULTICENTER STUDY; NEWBORN INFECTION; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PELVIC INFLAMMATORY DISEASE; PNEUMONIA; PRIORITY JOURNAL; PUERPERIUM; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYPHILIS; TREATMENT DURATION; TUBERCULOSIS; VIRUS TRANSMISSION; VOMITING;

EID: 84862873400     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)60321-3     Document Type: Article

References (41)

1. WHO. Guidelines on HIV and infant feeding: principles and recommendations for infant feeding in the context of HIV and a summary of evidence. Geneva: World Health Organization, 2010.
2. Chasela CS, Hudgens MG, Jamieson DJ, et al. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med 2010; 362: 2271-81.
3. Kilewo C, Karlsson K, Ngarina M, et al. Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study. J Acquir Immune Defic Syndr 2009; 52: 406-16.
4. Palombi L, Marazzi MC, Voetberg A, Magid NA. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV. AIDS 2007; 21 (suppl 4): S65-71. (Pubitemid 47051751)
5. Peltier CA, Ndayisaba GF, Lepage P, et al. Breastfeeding with maternal antiretroviral therapy or formula feeding to prevent HIV postnatal mother-to-child transmission in Rwanda. AIDS 2009; 23: 2415-23.
6. Shapiro RL, Hughes MD, Ogwu A, et al. Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med 2010; 362: 2282-94.
7. Thomas TK, Masaba R, Borkowf CB, et al. Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding-the Kisumu Breastfeeding Study, Kenya: a clinical trial. PLoS Med 2011; 8: e1001015.
8. Six Week Extended-Dose Nevirapine (SWEN) Study Team. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet 2008; 372: 300-13.
9. Kumwenda NI, Hoover DR, Mofenson LM, et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med 2008; 359: 119-29. (Pubitemid 351962035)
10. Thior I, Lockman S, Smeaton LM, et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA 2006; 296: 794-805. (Pubitemid 44223103)
11. Omer SB, Six Week Extended-Dose Nevirapine Study Team. Twelve-month follow-up of Six Week Extended Dose Nevirapine randomized controlled trials: differential impact of extended-dose nevirapine on mother-to-child transmission and infant death by maternal CD4 cell count. AIDS 2011; 25: 767-76.
12. WHO. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for a public health approach Geneva: World Health Organization, 2010.
13. van der Horst C, Chasela C, Ahmed Y, et al. Modifications of a large HIV prevention clinical trial to fit changing realities: a case study of the Breastfeeding, Antiretroviral, and Nutrition (BAN) protocol in Lilongwe, Malawi. Contemp Clin Trials 2009; 30: 24-33.
14. Moses A, Zimba C, Kamanga E, et al. Prevention of mother-to-child transmission: program changes and the effect on uptake of the HIVNET 012 regimen in Malawi. AIDS 2008; 22: 83-87. (Pubitemid 350294881)
15. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999; 354: 795-802. (Pubitemid 29415583)
16. Kayira D, Bentley ME, Wiener J, et al. A lipid-based nutrient supplement mitigates weight loss among HIV-infected women in a factorial randomized trial to prevent mother-to-child transmission during exclusive breastfeeding. Am J Clin Nutr 2012; 95: 759-65.
17. US Food and Drug Administration. FDA public health advisory for nevirapine (viramune). http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm051674. htm (accessed Jan 19, 2012).
18. Chavula C, Long D, Mzembe E, et al. Stopping the control arm in response to the DSMB: mother's choice of HIV prophylaxis during breastfeeding in the BAN Study. Contemp Clin Trials 2012; 33: 55-59.
19. WHO, UNICEF. Breastfeeding counselling: a training course. 1993. http://www.who.int/maternal-child-adolescent/documents/who-cdr-93-3/en/ (accessed Jan 19, 2012).
20. Phuka JC, Gladstone M, Maleta K, et al. Developmental outcomes among 18-month-old Malawians after a year of complementary feeding with lipid-based nutrient supplements or corn-soy flour. Matern Child Nutr 2012; 8: 239-48.
21. WHO. Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults. Geneva: World Health Organization, 2006.
22. Division of AIDS. Table for grading the severity of adult and pediatric adverse events, version 1.0-December 2004 (clarification August 2009). http://rsc.tech-res.com/Document/safetyandpharmacovigilance/Table-for-Grading- Severity-of-Adult-Pediatric-Adverse-Events.pdf (accessed Jan 30, 2012).
23. Emergency Nutrition Network. Measuring malnutrition: individual assessment. May, 2011. http://www.ennonline.net/pool/files/ife/m6-measuring- malnutrition,-individual-assessment-fact-sheet.pdf (accessed Jan 30, 2012).
24. Kerac M, Blencowe H, Grijalva-Eternod C, et al. Prevalence of wasting among under 6-month-old infants in developing countries and implications of new case definitions using WHO growth standards: a secondary data analysis. Arch Dis Child 2011; 96: 1008-13.
25. Alioum A, Dabis F, Dequae-Merchadou L, et al. Estimating the efficacy of interventions to prevent mother-to-child transmission of HIV in breast-feeding populations: development of a consensus methodology. Stat Med 2001; 20: 3539-56. (Pubitemid 33114426)
26. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141-54.
27. Coovadia HM, Brown ER, Fowler MG, et al. Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial. Lancet 2012; 379: 221-28.
28. Kesho Bora Study Group. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. Lancet Infect Dis 2011; 11: 171-80.
29. Fowler MG, Newell ML. Breast-feeding and HIV-1 transmission in resource-limited settings. J Acquir Immune Defic Syndr 2002; 30: 230-39. (Pubitemid 34664420)
30. WHO. New data on the prevention of mother-to-child transmission of HIV and their policy implications: WHO Technical Consultation on Behalf of the UNFPA/UNICEF/WHO/UNAIDS Inter-Agency Task Team on Mother-to-Child Transmission of HIV. Geneva: World Health Organization, 2001.
31. Parker ME, Bentley ME, Chasela C, et al. The acceptance and feasibility of replacement feeding at 6 months as an HIV prevention method in Lilongwe, Malawi: results from the BAN study. AIDS Educ Prev 2011; 23: 281-95.
32. Kuhn L, Aldrovandi GM, Sinkala M, et al. Effects of early, abrupt weaning on HIV-free survival of children in Zambia. N Engl J Med 2008; 359: 130-41. (Pubitemid 351962036)
33. Fawzy A, Arpadi S, Kankasa C, et al. Early weaning increases diarrhea morbidity and mortality among uninfected children born to HIV-infected mothers in Zambia. J Infect Dis 2011; 203: 1222-30.
34. Onyango-Makumbi C, Bagenda D, Mwatha A, et al. Early weaning of HIV-exposed uninfected infants and risk of serious gastroenteritis: findings from two perinatal HIV prevention trials in Kampala, Uganda. J Acquir Immune Defic Syndr 2010; 53: 20-27.
35. Kafulafula G, Hoover DR, Taha TE, et al. Frequency of gastroenteritis and gastroenteritis-associated mortality with early weaning in HIV-1-uninfected children born to HIV-infected women in Malawi. J Acquir Immune Defic Syndr 2010; 53: 6-13.
36. Arpadi S, Fawzy A, Aldrovandi GM, et al. Growth faltering due to breastfeeding cessation in uninfected children born to HIV-infected mothers in Zambia. Am J Clin Nutr 2009; 90: 344-53.
37. Homsy J, Moore D, Barasa A, et al. Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-Infected women on highly active antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr 2010; 53: 28-35.
38. Kuhn L, Sinkala M, Semrau K, et al. Elevations in mortality associated with weaning persist into the second year of life among uninfected children born to HIV-infected mothers. Clin Infect Dis 2010; 50: 437-44.
39. Taha TE, Hoover DR, Chen S, et al. Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi. Clin Infect Dis 2011; 53: 388-95.
40. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365: 493-505.
41. Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009; 360: 1815-26.